DOuBLED - Doubling Outcomes by Lung Cancer Early Diagnosis
Clinical trial NCT05091437 · COMPLETED
Trial details
- NCT number
- NCT05091437
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-30
- Primary completion
- 2024-11-30
- Enrollment
- 562
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.